Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2018. Start Trial.
Date Value
September 30, 2026 99.84%
August 31, 2026 99.84%
July 31, 2026 99.84%
June 30, 2026 99.84%
May 31, 2026 99.84%
April 30, 2026 99.84%
March 31, 2026 99.84%
February 28, 2026 99.84%
January 31, 2026 99.84%
December 31, 2025 99.84%
November 30, 2025 99.84%
October 31, 2025 99.84%
September 30, 2025 99.84%
August 31, 2025 99.84%
July 31, 2025 99.84%
June 30, 2025 99.84%
May 31, 2025 99.84%
April 30, 2025 99.84%
March 31, 2025 99.81%
February 28, 2025 99.75%
January 31, 2025 99.53%
December 31, 2024 98.90%
November 30, 2024 98.80%
October 31, 2024 94.04%
September 30, 2024 93.89%
Date Value
August 31, 2024 93.72%
July 31, 2024 93.03%
June 30, 2024 93.03%
May 31, 2024 93.03%
April 30, 2024 93.03%
March 31, 2024 86.69%
February 29, 2024 85.43%
January 31, 2024 85.43%
December 31, 2023 85.43%
November 30, 2023 85.43%
October 31, 2023 85.43%
September 30, 2023 84.52%
August 31, 2023 84.52%
July 31, 2023 84.52%
June 30, 2023 84.52%
May 31, 2023 84.52%
April 30, 2023 84.52%
March 31, 2023 84.52%
February 28, 2023 84.52%
January 31, 2023 84.52%
December 31, 2022 84.52%
November 30, 2022 84.42%
October 31, 2022 84.42%
September 30, 2022 84.42%
August 31, 2022 84.42%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Omeros Corp. 95.41%
Talphera, Inc. 99.48%
ANI Pharmaceuticals, Inc. 72.96%
Corcept Therapeutics, Inc. 71.85%
Veru, Inc. 99.12%